Iradimed (IRMD) Short-term Investments (2013 - 2022)

Iradimed (IRMD) has 10 years of Short-term Investments data on file, last reported at $500090.0 in Q1 2022.

• On a quarterly basis, Short-term Investments fell 73.72% year-over-year to $500090.0 in Q1 2022; TTM through Mar 2022 was $500090.0, a 73.72% decrease from a year earlier, with the FY2021 full-year figure at $501855.0, down 73.72% from the prior year.
• Short-term Investments for Q1 2022 stood at $500090.0, roughly flat from $501855.0 in the prior quarter.
• Over the last five years, Short-term Investments for IRMD reached as high as $8.2 million in Q2 2018 and fell as low as $500090.0 in Q1 2022.
• Historically, Short-term Investments has averaged $3.6 million across 5 years, with a median of $2.8 million in 2019.
• Across the five-year window, Short-term Investments climbed 16.34% in 2018 and plunged 73.72% in 2022, its largest moves.
• Year by year, Short-term Investments stood at $6.3 million in 2018, then sank by 56.4% to $2.8 million in 2019, then sank by 31.03% to $1.9 million in 2020, then slumped by 73.72% to $501855.0 in 2021, then slipped by 0.35% to $500090.0 in 2022.
• Per Business Quant data, the three most recent Short-term Investments figures were $500090.0 in Q1 2022, $501855.0 in Q4 2021, and $945066.0 in Q3 2021.